Small-cell carcinoma of the lung detected by CT screening: stage distribution and curability.

BACKGROUND Prognosis is incompletely known for small-cell lung carcinoma (SCLC) detected by CT screening of at-risk subjects. METHODS A multinational study of baseline and annual repeat CT screening for lung cancer of 48,037 at-risk subjects yielded 48 persons (median age 68 years) with SCLC. Stage (tumor, node, metastasis system) distribution and death rates were compared with those of 7960 usual-care SCLC subjects (chi-square or Fisher exact testing, as appropriate), as reported by the International Association for the Study of Lung Cancer. Cure was estimated by Kaplan-Meier analysis. RESULTS Forty-four (92%) of the patients were asymptomatic at screening CT detection of their SCLC; four (8%) presented with cancer-related symptoms before the next scheduled repeat screening. SCLC was diagnosed in clinical stages IA and IV in 16 (33%) and 7 (15%), respectively, of 48 patients, compared to 211 (3%) and 4530 (57%), respectively, of the 7960 patients in the usual-care study (P<0.0001). Tumor diameter was ≤3.0 cm for each of the 16 subjects in clinical stage I. The percentage of clinical stage I SCLC-related deaths within 5 years was lower in the screening study than in the usual-care study (44% vs. 71%, P=0.03), as was also the percentage of advanced stage (IIIB plus IV) SCLC-related deaths (62% vs. 94%, P<0.0001). CONCLUSIONS Compared to usual-care detection of SCLC, CT screening identified a shift toward early stage and away from late stage disease, and was associated with a decrease in deaths from the disease.

[1]  J. Jassem,et al.  A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[2]  Edward L Spitznagel,et al.  Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Zell,et al.  The Applicability of the Proposed IASLC Staging Revisions to Small Cell Lung Cancer (SCLC) with Comparison to the Current UICC 6th TNM Edition , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  R. Hatlevoll,et al.  The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up. , 2001, Lung cancer.

[5]  O. Miettinen,et al.  Early lung cancer action project pathology protocol. , 2003, Lung cancer.

[6]  M. Roizen.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[7]  H. Welch,et al.  Screening for disease. , 1997, AJR. American journal of roentgenology.

[8]  L. Wilson,et al.  Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  E. Stoelben,et al.  Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  M. Sheppard,et al.  Small Cell Lung Carcinoma (SCLC): A Clinicopathologic Study of 100 Cases With Surgical Specimens , 2002, The American journal of surgical pathology.

[11]  Kenji Eguchi,et al.  A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung Cancers , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  Cai-cun Zhou,et al.  The International Association for the Study of Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the Tumor,Node,Metastasis Classification for Lung Cancer , 2008 .

[13]  Hironobu Ohmatsu,et al.  Detection of unsuspected distant metastases and/or regional nodes by FDG-PET in LD-SCLC scan in apparent limited-disease small-cell lung cancer , 2007 .

[14]  C. Faivre-Finn,et al.  Radiotherapy for small-cell lung cancer-Where are we heading? , 2009, Lung cancer.

[15]  W. Hohenberger,et al.  Predictive and prognostic factors in small cell lung carcinoma (SCLC)--analysis from routine clinical practice. , 2006, Anticancer research.

[16]  Kari Chansky,et al.  The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  F. Shepherd.  Surgery for limited stage small cell lung cancer: time to fish or cut bait. , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[18]  David O Wilson,et al.  The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. , 2008, American journal of respiratory and critical care medicine.

[19]  J. Coebergh,et al.  Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. , 2001, Lung cancer.

[20]  S. Kaasa,et al.  Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen). , 2005, Lung cancer.

[21]  D. Aberle,et al.  CT screening for lung cancer. , 2007, The New England journal of medicine.

[22]  R. Wade,et al.  Small cell lung cancer treated in southeast Wales. , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

[23]  R. Hatlevoll,et al.  The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up , 2003 .

[24]  A. Nicholson,et al.  The Role of Surgery in the Treatment of Limited Disease Small Cell Lung Cancer: Time to Reevaluate , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[25]  E. Wynder,et al.  Lung cancer pathology in smokers, ex-smokers and never smokers. , 1995, Cancer letters.

[26]  A. Hackshaw,et al.  Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  O. Miettinen,et al.  Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size. , 2006, Archives of internal medicine.

[28]  R. Holle,et al.  Clinical relevance of histologic subtyping in small cell lung cancer , 1989, Cancer.

[29]  J. Crowley,et al.  The Impact of Additional Prognostic Factors on Survival and their Relationship with the Anatomical Extent of Disease Expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the Proposals for the 7th Edition , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[30]  Claudia I. Henschke,et al.  International Early Lung Cancer Action Program: Enrollment and Screening Protocol , 2011 .

[31]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[32]  W. Holland.  Screening for Disease , 1969, Nature.

[33]  Feng Li,et al.  CT findings of early-stage small cell lung cancer in a low-dose CT screening programme. , 2007, Lung cancer.